GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for tRNA N6-adenosine threonylcarbamoyltransferase (A2BVD2)

Analyse AlphaFold monomer V2.0 prediction for tRNA N6-adenosine… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
A2BVD2
Type
protein
Length
356 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xd10960F956646DE8b64d3598984c91C2d5Af3D7b
Molecule
TRNA N6-adenosine threonylcarbamoyltransferase
UniProt
A2BVD2
Pockets
3 · best druggability 0.66

Structure

1 distinct chain · 46% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATRNA N6-adenosine threonylcarbamoyltransferaseprotein35646% helix, 20% strandA2BVD2

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14320.660.7943empty
2640.420.8119empty
3730.320.7517empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.